جست‌وجوی استاد و پژوهشگر

Blanca I. Aldanaمشاهده پروفایل

دانشیار

• Brain energy metabolism
• Neurodegenerative disorders
• Glial cell function
• +۷ مورد دیگر

Blanca I. Aldana is an Associate Professor and Group leader of the NeuroMetabolism Research Group at the University of Copenhagen's Faculty of Health and Medical Sciences, Department of Drug Design and Pharmacology. Since 2024, she has served as Head of the Research Section in Molecular and Cellular Pharmacology. Her research focuses on unraveling central disease mechanisms to identify novel metabolic therapeutic targets in neurodegenerative disorders. Dr. Aldana's primary research areas include energy metabolism in the brain centered on glial cells (microglia and astrocytes) and their impact on neurological disorders such as epilepsy, Alzheimer's disease, and Frontotemporal dementia. She specializes in neuropharmacology targeting microglia and astrocyte receptors, with expertise in brain cell lines, primary cultures, transgenic animal models, and human induced pluripotent stem cells. Her laboratory employs advanced analytical methods including mass spectrometry, liquid chromatography, and live-cell bioenergetics. Her recent publications demonstrate a strong focus on brain energy metabolism, particularly examining glial cell function in neurodegenerative conditions. The research spans molecular and cellular mechanisms of brain energy and amino acid metabolism, pathophysiology of glial energy metabolism in neurodegeneration, and mechanistic insights into the effects of short-chain and medium-chain fatty acids on brain metabolism. This work has significant implications for developing novel therapeutic strategies for neurodegenerative diseases. 2024: Alzheimer-forskningsfonden Research Prize 2023: Nominated as Teacher of the Year, University of Copenhagen 2023: Emerging Investigator Award, International Society for Neurochemistry 2020: IBRO Early Career Award Dr. Aldana has supervised and mentored numerous Postdocs, PhD students, MSc students, and BSc students. She serves as course director for Farmaceutisk biologi and teaches in 'In-Vitro Techniques in Biochemistry and Pharmacology,' 'Principles of Pharmacology' for the MSc Neuroscience Program, and Physiology. She is also a member of the Drug Research Academy and Neuroscience Academy Denmark's Neuroinflammation column, and serves as communication responsible for the Metabolism and Inflammation Research Cluster.

Jens Christian Reklingمشاهده پروفایل

دانشیار

• Cellular Neurophysiology
• Systems Neurophysiology
• Brainstem Neurons
• +۵ مورد دیگر

Jens Christian Rekling is an Associate Professor at the Department of Neuroscience and Pharmacology within the Faculty of Health Sciences at the University of Copenhagen. His research focuses on understanding neural mechanisms underlying motor behavior and sensory processing, with particular emphasis on brainstem circuits involved in respiratory control. Dr. Rekling directs the Rekling Lab, which maintains active research programs investigating neural microcircuit function. Dr. Rekling graduated as a Medical Doctor in 1988 and completed his Medical Doctorate (dr.med.) in Neuroscience in 1999. His academic journey includes postdoctoral work at Copenhagen University, research positions at C.N.R.S in Paris, UCLA, and H. Lundbeck A/S before returning to academia at the University of Copenhagen. His career progression shows a consistent trajectory from research scientist to academic faculty member with leadership roles including Vice-Chair of the Department (2007-2011). Dr. Rekling's research program investigates how small assemblies of neurons interact to produce sensory and motor functions in the brain. His laboratory employs electrophysiological and optical techniques to study living neurons in preparations that maintain functional sensori-motor systems under in vitro conditions. Key research questions address neural microcircuit mechanisms involved in generating breathing movements, precision movements, and developmental processes specifying functional microcircuits. His work bridges cellular neurophysiology with systems-level understanding of motor control, with particular focus on brainstem respiratory networks and the olivocerebellar system. Analysis of Dr. Rekling's recent publications (2018-2025) reveals a strong focus on brainstem neural circuits, particularly the PreBötzinger complex involved in respiratory rhythm generation. His work spans multiple techniques including electrophysiology, calcium imaging, and organotypic slice cultures. Recent research explores neuropeptide modulation of neural circuits (TRH, opioids), gut-brain axis communication via vagal pathways, and the role of specific receptors in neural signaling. His interdisciplinary approach combines neuroscience, physiology, and pharmacology to address fundamental questions about neural circuit function, with implications for understanding neurological disorders affecting motor control. Dr. Rekling maintains active academic service roles including membership on the Graduate Programme in Neuroscience (serving as Chair in 2014) and the Aftagerpanelet for den Lægevidenskabelige Bachelor- og Kandidatuddannelse (2015). He has been a member of various University of Copenhagen committees since 2008, demonstrating ongoing institutional engagement beyond his research and teaching responsibilities. At the Rekling Lab, Dr. Rekling continues to investigate the cellular and network mechanisms underlying motor behavior, with the ultimate goal of understanding simple motor or sensory behaviors from the cellular to the network level. His research program remains active with publications through 2025, indicating continued scientific productivity and relevance in the field of neurophysiology.

Niels Skotteمشاهده پروفایل

استادیار

• Neuroscience
• Huntington's Disease
• Proteomics
• +۵ مورد دیگر

Niels Skotte serves as an Assistant Professor in the Department of Drug Design and Pharmacology within the Faculty of Health and Medical Sciences at the University of Copenhagen. He is affiliated with the Novo Nordisk Foundation Center for Protein Research, where he conducts cutting-edge research in neurodegenerative diseases and proteomics. Dr. Skotte earned his PhD in neuroscience in 2011 from the Department of Cellular and Molecular Medicine at the University of Copenhagen. Following his doctoral studies, he completed a postdoctoral fellowship at the Centre for Molecular Medicine and Therapeutics in Vancouver, Canada, working with Prof. Michael Hayden, a world-leading expert in Huntington's disease. In 2015, he returned to Denmark to join Dr. Matthias Mann's laboratory, a pioneer in modern protein research. His primary research focus centers on Huntington's disease, where he has worked for over a decade, developing allele-selective anti-sense oligonucleotides and investigating strategies to limit huntingtin processing by modulating caspase-6 activity. Since 2015, his work has expanded into biofluid mass spectrometry, with current research focusing on identifying novel biomarkers and therapeutic targets for neurodegenerative diseases, particularly temporal protein changes in cerebrospinal fluid and plasma from Huntington's disease patients. His recent publications demonstrate expertise in molecular pharmacology, neurodegeneration mechanisms, and advanced proteomic techniques. Analysis of his most recent publications reveals a strong focus on neurodegenerative disease mechanisms, with particular attention to Huntington's disease, Alzheimer's disease, and related disorders. His work integrates molecular biology, proteomics, and neuroscience to understand disease progression and identify potential therapeutic targets. The research spans from basic molecular mechanisms to translational applications, with increasing emphasis on biomarker discovery and validation. Dr. Skotte maintains active collaborations with researchers across multiple institutions, as evidenced by his co-authorship on numerous publications with colleagues at the University of Copenhagen and international partners. His work has gained significant attention in the scientific community, with multiple publications receiving substantial citations and mentions across various academic platforms. He is part of the research environment led by Dr. Matthias Mann at the Novo Nordisk Foundation Center for Protein Research, which provides state-of-the-art facilities for proteomic analysis. This collaborative environment supports his work on identifying protein changes associated with neurodegenerative diseases, leveraging advanced mass spectrometry techniques to analyze complex biological samples.

Bente Frølundمشاهده پروفایل

استاد

• Pharmacology
• Medicinal Chemistry
• Neuropharmacology
• +۷ مورد دیگر

Bente Frølund is a Professor in the Department of Drug Design and Pharmacology at the Faculty of Health and Medical Sciences, University of Copenhagen. Her research focuses on neuropharmacology with emphasis on GHB/CaMK2 pharmacology and ionotropic GABA A receptors, as well as nACh receptors and GABA transporters. Her research interests include: GHB/CaMK2 pharmacology Ionotropic GABA A receptors Nicotinic acetylcholine receptors (nACh) GABA transporters (GAT and TauT) Structure-activity relationship studies Development of photoligands for protein localization and activation Engineered molecular probes for ligand-protein interactions Professor Frølund's recent publications demonstrate a strong focus on receptor pharmacology, particularly exploring the interactions between GHB ligands and CaMKIIα, as well as the development of novel ligands for GABA A and nicotinic acetylcholine receptors. Her work combines medicinal chemistry approaches with neuropharmacological evaluation to develop molecular tools for studying receptor function and potential therapeutic applications, with neuroprotection being a key focus area. Her scientific contributions include 178 research outputs as documented in her publication record, spanning journal articles, book chapters, patents, and conference presentations. Her work has been referenced in Wikipedia pages, picked up by news outlets, and discussed on social media platforms including X, Facebook, Bluesky, and Reddit. Professor Frølund collaborates extensively with researchers both within the University of Copenhagen and internationally, as indicated by the network visualization in her profile. Her laboratory develops molecular probes and novel methodologies to gain insight into the identity, localization, function, and therapeutic potential of target receptors and transporters.

• Neuropharmacology
• Brain Metabolism
• Alzheimer's Disease Research
• +۴ مورد دیگر

Emil Winther Westi is a Research Fellow at the University of Copenhagen's Faculty of Health and Medical Sciences within the Department of Drug Design and Pharmacology and Molecular and Cellular Pharmacology research group. His work focuses on brain metabolism mechanisms and their implications in neurological disorders. Dr. Westi's research spans critical neuroscience domains: Neuropharmacology and drug design Brain metabolism in health and disease Alzheimer's disease mechanisms and models Stroke pathophysiology and preclinical models Glioma cell metabolism and signaling Cerebrospinal fluid dynamics and choroid plexus function His publication record demonstrates expertise in metabolic mapping of neuronal and glial cells, with emphasis on how metabolic processes change in neurological conditions. He employs advanced techniques including dMRI, immunohistochemistry, and functional metabolic mapping across multiple disease models. Dr. Westi has published in high-impact journals such as Nature Communications, Glia, and Journal of Cerebral Blood Flow and Metabolism. His work has received significant academic attention with multiple papers highlighted in news outlets and social media platforms, indicating strong relevance to current neurological research.

Simon C. Corkمشاهده پروفایل

مدرس ارشد

• Physiology
• Obesity Research
• Medical Education
• +۳ مورد دیگر

Dr Simon C. Cork serves as Senior Lecturer at Anglia Ruskin University's School of Medicine, holding key leadership roles including Admissions Lead, Phase 1 Lead for the MBChB program, co-lead for Widening Participation, and Physiology Lead. His career uniquely integrates neurophysiological research on obesity mechanisms with national reform of medical education access. His academic credentials include: BSc (Hons) Biomedical Science, Durham University (2008) PhD in Neurophysiology, Durham University (2013) PGCert in Clinical Education, King's College London (2020) Dr Cork's research spans obesity physiology —focusing on gut hormones like GLP-1 and vagus nerve signaling in appetite regulation—and educational equity , where he designs admissions frameworks to identify potential beyond traditional metrics. His dual expertise drives innovations in both pharmacotherapeutic understanding and inclusive medical training pathways. Analysis of his 15 most recent publications reveals two dominant trajectories: cutting-edge investigations into GLP-1 receptor agonists' mechanisms (including post-bariatric applications) and transformative medical education research addressing widening participation through AI tools, alternative qualifications, and online assessment systems. This synergy positions him at the intersection of physiological discovery and educational reform. His distinguished contributions are recognized through: 2026 Widening Participation in Physiology Prize Lecture (Physiological Society) As an educator, Dr Cork supervises research students while shaping national policy via UCAT Board membership to dismantle admission barriers. His public engagement—evidenced by BBC documentaries, Cheltenham Science Festival appearances, and New York Times coverage—translates complex science for global audiences, particularly regarding anti-obesity medications. Collaborating with Imperial College London and University College London, he maintains active neurophysiology research while leading ARU's Medical School initiatives through the Medical Schools Council Selection Alliance and Physiological Society fellowship.

• Neurosciences
• Parkinson's Disease
• Autism Spectrum Disorders
• +۵ مورد دیگر

Dr. Anders Borgkvist is a Principal Researcher at the Department of Neuroscience, Karolinska Institutet, where he leads the Anders Borgkvist group . His research focuses on molecular and circuit-level mechanisms in neurodevelopmental and neurodegenerative disorders, with emphasis on dopamine signaling, synaptic plasticity, and basal ganglia pathophysiology. Research Interests: Dr. Borgkvist's work spans Parkinson's disease, autism spectrum disorders, and neuropharmacology. Key areas include: Dopamine-serotonin/acetylcholine cotransmission in striatonigral pathways Synaptic filtering and plasticity in motor sensitization mTOR/autophagy dysregulation in neurodevelopment KCC2-mediated GABAergic inhibition in Parkinsonian motor deficits Grants: Swedish Research Council (2025–2028): Targeting dysregulated basal ganglia output in Parkinson’s disease (investigating KCC2 enhancement as therapy). Swedish Research Council (2017–2020): Synaptic plasticity at dopamine synapses in motor cortex during motor learning . Swedish Research Council (2009–2011): Optical studies on synaptic mechanisms of learning and addiction . His lab utilizes cutting-edge techniques including in vivo fiber photometry, GCaMP imaging, and transgenic models to dissect neural circuit dysfunctions. Collaborations include international experts in neurochemistry and movement disorders.

Atiyah Yahyaمشاهده پروفایل

دانشیار

• Magnetic Resonance Spectroscopy
• In-vivo Metabolite Quantification
• Lipid MRS
• +۶ مورد دیگر

Atiyah Yahya, Ph.D., FCCPM, P.Eng., FCOMP is an Associate Professor in the Division of Medical Physics within the Department of Oncology at the University of Alberta's Faculty of Medicine & Dentistry. He serves as Senior Medical Physicist at the Cross Cancer Institute's Department of Medical Physics, conducting research using 3T and 9.4T MRI scanners. Education: Ph.D. in Medical Sciences (Biomedical Engineering and Electrical/Computer Engineering), University of Alberta B.Sc. in Engineering Physics, University of Alberta Yahya's research focuses on in-vivo magnetic resonance spectroscopy (MRS) with emphasis on lipid and brain metabolite quantification. His work develops advanced MRS techniques for measuring cancer-relevant metabolites, particularly improving proton MRS quantification of lipids and applying MRS to monitor treatment responses. His laboratory utilizes both 3T and 9.4T MRI systems at the Cross Cancer Institute for technical development and clinical applications. Analysis of his 15 most recent publications reveals a consistent focus on MRS methodology refinement (80% of works), particularly PRESS/STEAM sequence optimization for metabolite separation at high fields. Key technical themes include J-coupling effects (47% of papers), lipid composition analysis (33%), and neurotransmitter quantification (20%). His research bridges physics innovation with clinical oncology applications, with 60% of recent work directly addressing cancer metabolism. Scientific Awards: Fellow of the Canadian College of Physicists in Medicine (FCCPM) Professional Engineer (P.Eng.) - APEGA Fellow of the Canadian Organization of Medical Physicists (FCOMP) CCPM Certification in Diagnostic Radiological Physics and MRI Physics Yahya directs the Medical Physics Imaging Residency Program and coordinates multiple graduate courses including Oncol 556 (Laboratory in Imaging) and Oncol 691 (Advanced Magnetic Resonance Physics). His teaching portfolio spans diagnostic radiology physics (MEDPH 468/ONCOL 568), advanced MRI methods (ONCOL 690), and research seminars (ONCOL 600). While specific grant details aren't provided, his extensive publication record in high-impact journals suggests significant research funding support. His laboratory operates within the Cross Cancer Institute's imaging facilities, leveraging the institute's 3T and 9.4T MRI platforms for both technical development and clinical translation of MRS techniques.

Michael Brechtمشاهده پروفایل

استاد

• Neuroscience
• Somatosensory Cortex
• Memory Consolidation
• +۶ مورد دیگر

Michael Brecht is a Professor at Humboldt University of Berlin, Faculty of Life Sciences, Department of Biology. His research focuses on neural mechanisms underlying somatosensory processing, memory consolidation, kinship behavior, and social play. He leads a research group investigating brain circuits related to these functions, with particular emphasis on the lateral septum, periaqueductal gray, and somatosensory cortex. Professor Brecht's research interests include: Neural circuits for somatosensory processing and body map representation Mechanisms of memory consolidation from synapses to systems Neural basis of kinship behavior and social recognition Neurobiology of social play and vocal communication Spatial coding and navigation systems in the brain His recent publications reveal a consistent focus on understanding how specific brain regions encode social and sensory information. Brecht's work frequently employs advanced techniques including electrophysiology, calcium imaging, optogenetics, and large-scale neural recording to investigate circuit mechanisms. A notable trend in his research is the investigation of sex differences in neural processing, particularly in genital somatosensory representation, and the identification of specialized neural architectures for social behaviors like kinship recognition. Scientific contributions include: Discovery of nepotopy (topographical representation of kin/nonkin) in the lateral septum Demonstration of sex differences in genital cortex representation Identification of glycine-dependent mechanisms in social play behavior Mapping of vocalization-related activity in brainstem nuclei Elucidation of perirhinal input mechanisms for neocortical learning Professor Brecht actively mentors students and collaborates with researchers across multiple institutions. His laboratory investigates both fundamental neural mechanisms and their implications for understanding social behavior. Current work appears focused on understanding the molecular and circuit-level basis of kinship memory and the neural substrates of social play behavior across development.

Daniel Hollernمشاهده پروفایل

استادیار

• Cancer Immunology
• Breast Cancer Research
• Tumor-Immune Cell Interactions
• +۳ مورد دیگر

Daniel Hollern is an Assistant Professor at the Salk Institute for Biological Studies, where he leads the Hollern Lab within the NOMIS Center for Immunobiology and Microbial Pathogenesis. His research focuses on understanding tumor-immune cell interactions, with particular emphasis on B cells in cancer immunity. Dr. Hollern's educational background includes a PhD in Cell and Molecular Biology from Michigan State University, postdoctoral training at the University of North Carolina, and a Bachelor of Science in Biology from Grand Valley State University. Hollern's research interests center on cancer immunology, specifically investigating how B cells contribute to anti-tumor immune responses. His lab has made groundbreaking discoveries showing that B cells are key regulators of response to immune checkpoint inhibitors, particularly in triple-negative breast cancer. His work demonstrates that patients with tumor-infiltrating B cells have higher response rates to chemotherapy and immunotherapy. The lab's research explores B cell interactions with CD4+ T cells, antibody production against tumor cells, and the mechanisms by which B cells drive curative responses to immunotherapy. Current investigations focus on leveraging B cells therapeutically to improve cancer treatment outcomes. Analysis of Dr. Hollern's recent publications reveals a consistent focus on B cell immunology in cancer, with particular emphasis on triple-negative breast cancer. His work spans basic immunological mechanisms, translational applications, and clinical implications of B cell activity in tumor microenvironments. The research demonstrates how B cells interact with other immune components like T follicular helper cells and interleukin 21 to mediate anti-tumor responses. 2019 Joseph Pagano Award 2015 NIH NCI F32 Ruth L. Kirschstein National Research Service Award 2014 NIH NCI F31 Ruth L. Kirschstein National Research Service Award 2014 Aitch Foundation Award The Hollern Lab maintains a strong focus on mentoring and collaboration, emphasizing diversity, inclusion, and equitable scientific practices. The lab culture prioritizes building a supportive environment for tackling complex cancer research questions through interdisciplinary approaches. Dr. Hollern's research program represents a significant contribution to understanding how to harness the immune system, particularly B cells, to develop more effective cancer treatments with long-term disease control.

Daryl L. Daviesمشاهده پروفایل

استاد بالینی

• Alcohol Use Disorders
• Purinergic Receptors
• Neurodegenerative Diseases
• +۵ مورد دیگر

Daryl L. Davies, PhD, is Professor of Clinical Pharmacy and Associate Dean for Undergraduate Education at the University of Southern California School of Pharmacy. He oversees undergraduate programs including the Trojan Admission Pre-Pharmacy (TAP) initiative and directs the SC-ACE research program for high school students. His primary appointment is in the Titus Family Department of Clinical Pharmacy. Research Focus Dr. Davies leads interdisciplinary research targeting alcohol use disorders and neurodegenerative diseases. His laboratory investigates: Purinergic receptor mechanisms in alcohol intake regulation Novel therapeutics like ivermectin and dihydromyricetin for addiction Neuroimmune interactions in alcoholism-neurodegeneration comorbidity Gut-brain axis modulation via sodium butyrate High-throughput drug discovery approaches Publication Trends Recent articles (2019-2025) demonstrate three dominant themes: Preclinical validation of anti-alcohol compounds targeting P2X4 receptors and neuroinflammation Pharmaceutical technology innovations for CNS drug delivery Educational research on adaptive curricula in pharmacy training Neuropharmacology accounts for 80% of publications, with consistent focus on translational rodent models. Grants & Leadership Active funding includes: NIH R01AA022448 ($3.2M, 2016-2021): Purinergic regulation of alcohol intake AgeneBio subcontract: GABA-A α5 modulators for cognitive impairment He directs the Alcohol and Brain Research Laboratory and co-leads the USC Addiction Science Institute, collaborating with 15+ investigators across pharmacology, chemistry, and neuroscience.

Sebastian Bargمشاهده پروفایل

استاد

• Cell Biology
• Endocrinology
• Insulin Secretion
• +۵ مورد دیگر

Sebastian Barg is a Professor and Deputy Head of Department at Uppsala University's Department of Medical Cell Biology within the Faculty of Medicine. His research group investigates the cell biology of insulin secretion using advanced light microscopy (TIRF, single molecule imaging) and patch clamp electrophysiology, with a particular focus on regulated exocytosis of secretory granules. He also teaches cell biology and general endocrinology courses. MSc Biochemistry, Free University Berlin (1995) Undergraduate thesis, Vanderbilt University (1995) PhD Medical Sciences, Lund University (2001) Barg's research primarily centers on pancreatic beta cell function, insulin secretion mechanisms, and diabetes pathophysiology. His work employs cutting-edge techniques to study vesicle dynamics, membrane fusion events, and molecular signaling pathways involved in exocytosis. The lab has made significant contributions to understanding how calcium channels, phosphoinositides, and SNARE proteins regulate insulin granule release. Their research has important implications for understanding Type 2 diabetes mechanisms where these processes are impaired. Analysis of Barg's most recent publications reveals a clear trajectory of increasingly sophisticated investigation into beta cell function. His work has evolved from fundamental studies of exocytosis mechanisms to complex investigations of diabetes pathology in human islets, incorporating advanced computational methods like deep learning for image analysis. The research spans molecular biology, cellular physiology, and translational medicine, consistently focusing on the mechanisms underlying insulin secretion defects in diabetes. Recent work has expanded into stem cell-derived islets, GLP-1 receptor signaling, and novel therapeutic targets for diabetes treatment. best PhD thesis Medical faculty Lund (2001) Swedish Research Council (VR) assistant professor position (2002) EMBO longterm fellowship (2002) STINT fellowship award (2002) Swedish Society for Medical Research fellowship award (2002) Albert Renold Career Development Award (EFSD) (2002) Wallenberg fellowship award in Nano/micro Science (2005) Zetterling fellowship award (2008) Göran Gustafsson award in human biology (2008-11) Professor Barg leads a vibrant research group comprising PhD students, postdoctoral researchers, and senior scientists. His lab has secured substantial funding from major Swedish and international research councils, including the Wallenberg Foundation and the Swedish Research Council. The research has significant translational potential, with several publications highlighting potential therapeutic targets for diabetes treatment. The group maintains active collaborations with other leading diabetes research teams both within Uppsala University and internationally. The Barg lab operates within Uppsala University's Department of Medical Cell Biology, utilizing state-of-the-art microscopy and electrophysiology facilities. The research group includes several key personnel such as Nikhil Gandasi (Researcher), Muhmmad Omar-Hmeadi (Postdoctoral position), and Emmanuel Chadeuf (PhD student), who have co-authored multiple high-impact publications with Barg. The lab's technical expertise spans molecular biology, advanced imaging, and computational analysis of cellular processes.

Arpiar Saundersمشاهده پروفایل

استادیار

• single-cell genomics
• host-virus interactions
• neural circuits
• +۲ مورد دیگر

Arpiar Saunders is an Assistant Professor at the Vollum Institute, Oregon Health & Science University, leading research on neural circuit organization through innovative genomic approaches. His work bridges neuroscience, virology, and computational biology to decode synaptic wiring principles. His educational background includes: B.A. in Biology and Linguistics from Swarthmore College (2006) Ph.D. in Neuroscience from Harvard Medical School (2014) Dr. Saunders' research focuses on developing single-cell and single-virion genomic technologies to map synaptic connections and investigate host-virus interactions in neural tissue. His lab pioneers methods like viral barcoding to correlate molecular profiles with circuit architecture, addressing how genetic variation impacts brain connectivity in psychiatric disorders. Key interests span synaptic biology, neural diversity, and comparative circuit evolution. His publication record reveals a strong interdisciplinary trajectory, integrating genomics and virology to advance neural mapping. Recent work emphasizes quantitative reconstruction of synaptic relationships from RNA-seq data and characterization of cell-type-specific wiring. Major recognitions include: Helen Hay Whitney Postdoctoral Fellowship (2016–19) NIH F31 Predoctoral Fellowship (2011–14) Harvard's Richard J. Herrnstein Dissertation Award (2014) As principal investigator of the Saunders Lab, he directs a team developing cutting-edge genomic tools to dissect neural circuit organization, with ongoing projects examining virus-brain interactions and synaptic vulnerability in disease contexts.

Laurence Trussellمشاهده پروفایل

استاد

• Auditory Neuroscience
• Synaptic Physiology
• Neural Circuits
• +۱ مورد دیگر

Laurence Trussell is a Professor and Interim Director of the Oregon Hearing Research Center at Oregon Health & Science University (OHSU), with concurrent appointment as a Scientist at the Vollum Institute. His research focuses on neural mechanisms of hearing, particularly brainstem circuitry and synaptic physiology in auditory processing. Education: Ph.D. in Biology, University of California, Los Angeles (1983) Research Interests: Dr. Trussell investigates how brainstem circuits encode acoustic signals and how synaptic physiology preserves auditory information. His seminal work demonstrates that timing-encoding neurons are molecularly specialized, reveals synaptic learning mechanisms at early sensory stages, and elucidates co-release of transmitters acting on single receptors. His research integrates molecular, biophysical, and circuit-level approaches to dissect auditory processing. Publication Trends: His 2013-2025 publications consistently explore dorsal cochlear nucleus physiology, emphasizing synaptic transmission mechanisms ( e.g. , glutamate dynamics, KCNQ channels), neural oscillations, electrical coupling, and cell-type-specific circuitry. Key themes include calcium channel nanodomains, inhibitory neuron subtypes, and multimodal integration, reflecting his focus on fundamental mechanisms of auditory signal processing from cellular to circuit levels. Advising and Grants: Publicly available information does not specify doctoral advisees or grant funding details, though his leadership of major research centers implies significant mentorship and extramural support. Labs and Teams: He directs research at the Oregon Hearing Research Center and Vollum Institute, leading teams studying auditory pathways through electrophysiology, imaging, and molecular techniques to decode hearing mechanisms and disorders.

• Biochemistry
• Ecology
• Plant Biology
• +۴ مورد دیگر

Dr. Sang-Gyu Kim is an Associate Professor in the Department of Biological Sciences at KAIST, leading the Laboratory for Molecular Ecology (EcoLab) since its establishment in 2017. His research bridges molecular biology and ecology to investigate plant chemical defense mechanisms against herbivores and pollinator attraction strategies. Research focuses on plant-insect interactions , specializing in the biosynthesis of defensive metabolites and floral volatiles. His lab employs cutting-edge techniques including single-cell RNA sequencing, metabolic engineering, and field ecology across diverse environments from Korean farmlands to the Great Basin Desert. Key model systems include Nicotiana attenuata and Arabidopsis thaliana . Recent publications reveal breakthroughs in: Herbivore-induced GABA signaling pathways (2025) MYC transcription factor networks in stem defense (2025) Multimodal pollination strategies in Aristolochiaceae (2025) These demonstrate his lab's leadership in connecting molecular mechanisms to ecological functions. Award highlights: Korean Society of Ecology Outstanding Paper Award (2022) Best Poster Presentation Award (2020) Mentorship excellence is evidenced by 15+ PhD/Master's students including Kang Moonyoung (2023), Choi Yuri (2024), and Song Junyong (2022), with ongoing collaborations across KAIST, Seoul National University, and international polar research institutes. Current fieldwork spans Brunei, Jeju Island, and Bulgoksan Mountain for volatile collection and ecological validation.